SOLUBLE AND CELLULAR MARKERS OF IMMUNE ACTIVATION IN PATIENTS WITH SYSTEMIC-SCLEROSIS

被引:44
作者
DEGIANNIS, D [1 ]
SEIBOLD, JR [1 ]
CZARNECKI, M [1 ]
RASKOVA, J [1 ]
RASKA, K [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT LAB MED & PATHOL,NEWARK,NJ 07103
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1990年 / 56卷 / 02期
关键词
D O I
10.1016/0090-1229(90)90147-I
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The peripheral blood lymphocyte pattern, the lymphocyte responses in vitro, as well as the soluble markers of immune activation were studied in 24 patients with systemic sclerosis (SSc patients). The proportions of total T cells (CD3), their CD4 subset, as well as B lymphocytes were within the normal range. The relative proportion of CD8 lymphocytes, however, was significantly reduced. Patients with SSc had a slightly lower percentage of CD4 4B4+ cells, whereas their proportion of CD4 2H4+ cells was elevated as compared to healthy controls. The proportion of lymphocytes expressing the interleukin-2 receptor (IL-2R) was significantly higher in SSc patients. The proliferative responses of peripheral blood mononuclear cells to PHA stimulation were reduced in the patient group, while expression of IL-2R on lymphocytes after such in vitro stimulation was comparable to that of controls. Expression of IL-2R on patient but not control lymphocytes was increased after in vitro exposure to laminin. Such exposure failed to induce IL-2 production or cell proliferative responses. Soluble plasma IL-2R level (sIL-2R) and soluble CD8 (sCD8) molecule levels in SSc patients were significantly elevated. These results indicate the presence of an ongoing lymphocyte activation in this disease process. © 1990.
引用
收藏
页码:259 / 270
页数:12
相关论文
共 29 条
  • [1] ALCOCERVARELA J, 1984, J RHEUMATOL, V11, P48
  • [2] DIFFERENCES IN THE PRODUCTION OF AND OR THE RESPONSE TO INTERLEUKIN-2 BY LYMPHOCYTES-T FROM PATIENTS WITH THE VARIOUS CONNECTIVE-TISSUE DISEASES
    ALCOCERVARELA, J
    LAFFON, A
    ALARCONSEGOVIA, D
    [J]. RHEUMATOLOGY INTERNATIONAL, 1984, 4 (01) : 39 - 44
  • [3] SERUM LEVELS OF INTERLEUKIN-2 RECEPTOR AND ACTIVITY OF RHEUMATIC DISEASES CHARACTERIZED BY IMMUNE-SYSTEM ACTIVATION
    CAMPEN, DH
    HORWITZ, DA
    QUISMORIO, FP
    EHRESMANN, GR
    MARTIN, WJ
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (11): : 1358 - 1364
  • [4] PROPERTIES OF A BASEMENT MEMBRANE-RELATED GLYCOPROTEIN SYNTHESIZED IN CULTURE BY A MOUSE-EMBRYONAL CARCINOMA-DERIVED CELL-LINE
    CHUNG, AE
    JAFFE, R
    FREEMAN, IL
    VERGNES, JP
    BRAGINSKI, JE
    CARLIN, B
    [J]. CELL, 1979, 16 (02) : 277 - 287
  • [5] CZIRJAK L, 1985, ACTA MED HUNG, V42, P129
  • [6] SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH SYSTEMIC-SCLEROSIS - CLINICAL AND LABORATORY CORRELATIONS
    DEGIANNIS, D
    SEIBOLD, JR
    CZARNECKI, M
    RASKOVA, J
    RASKA, K
    [J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (03): : 375 - 380
  • [7] ABNORMAL LYMPHOCYTE FUNCTION IN SCLERODERMA - A STUDY ON IDENTICAL-TWINS
    DUSTOOR, MM
    MCINERNEY, MM
    MAZANEC, DJ
    CATHCART, MK
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 44 (01): : 20 - 30
  • [8] DEFICIENCY OF THE SUPPRESSOR INDUCER SUBSET OF LYMPHOCYTES-T IN RHEUMATOID-ARTHRITIS
    EMERY, P
    GENTRY, KC
    MACKAY, IR
    MUIRDEN, KD
    ROWLEY, M
    [J]. ARTHRITIS AND RHEUMATISM, 1987, 30 (08): : 849 - 856
  • [9] FREUNDLICH B, 1987, CLIN EXP IMMUNOL, V69, P375
  • [10] FUJIMOTO J, 1983, J EXP MED, V159, P752